expert reaction to CRISPR-based gene editing tools used to correct Duchenne Muscular Dystrophy mutations in mice

A study published in Science Advances demonstrates the effectiveness of two CRISPR-based gene editing technologies for correcting Duchenne Muscular Dystrophy (DMD) mutations in mice.   Prof Robin Lovell-Badge, Group Leader, The Francis Crick Institute, said: “This is a complex story, due to the complex nature of the gene encoding Dystrophin…

Continue Reading expert reaction to CRISPR-based gene editing tools used to correct Duchenne Muscular Dystrophy mutations in mice

End of content

No more pages to load